OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial
Matthew C. Riddle, Hertzel C. Gerstein, Denis Xavier, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 5, pp. 1345-1351
Open Access | Times Cited: 21
Matthew C. Riddle, Hertzel C. Gerstein, Denis Xavier, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 5, pp. 1345-1351
Open Access | Times Cited: 21
Showing 21 citing articles:
Cardiovascular disease in the elderly: proceedings of the European Society of Cardiology—Cardiovascular Round Table
Maddalena Lettino, Julia Mascherbauer, Matias Nordaby, et al.
European Journal of Preventive Cardiology (2022) Vol. 29, Iss. 10, pp. 1412-1424
Open Access | Times Cited: 34
Maddalena Lettino, Julia Mascherbauer, Matias Nordaby, et al.
European Journal of Preventive Cardiology (2022) Vol. 29, Iss. 10, pp. 1412-1424
Open Access | Times Cited: 34
Evaluation of glucose-lowering medications in older people: a comprehensive systematic review and network meta-analysis of randomized controlled trials
Ssu-Yu Pan, En-Lin Su, Chi‐Jung Huang, et al.
Age and Ageing (2024) Vol. 53, Iss. 8
Closed Access | Times Cited: 6
Ssu-Yu Pan, En-Lin Su, Chi‐Jung Huang, et al.
Age and Ageing (2024) Vol. 53, Iss. 8
Closed Access | Times Cited: 6
Change in albuminuria as a surrogate endpoint for cardiovascular and renal outcomes in patients with diabetes
Biff F. Palmer
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 6, pp. 1434-1443
Open Access | Times Cited: 14
Biff F. Palmer
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 6, pp. 1434-1443
Open Access | Times Cited: 14
Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review
Katherine Young, Eram Haider McInnes, Robert Massey, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 14
Katherine Young, Eram Haider McInnes, Robert Massey, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 14
Cardiovascular effects of non-insulin glucose-lowering agents: a comprehensive review of trial evidence and potential cardioprotective mechanisms
Gianluigi Savarese, Javed Butler, Lars H. Lund, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 10, pp. 2231-2252
Open Access | Times Cited: 32
Gianluigi Savarese, Javed Butler, Lars H. Lund, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 10, pp. 2231-2252
Open Access | Times Cited: 32
Cardiovascular prevention in elderly patients.
Clara Bonanad, Rosa Fernández-Olmo, Sergio García‐Blas, et al.
PubMed (2022) Vol. 19, Iss. 5, pp. 377-392
Closed Access | Times Cited: 13
Clara Bonanad, Rosa Fernández-Olmo, Sergio García‐Blas, et al.
PubMed (2022) Vol. 19, Iss. 5, pp. 377-392
Closed Access | Times Cited: 13
Evaluating the Impact of Novel Incretin Therapies on Cardiovascular Outcomes in Type 2 Diabetes: An Early Systematic Review
Teodor Salmen, Claudia-Gabriela Potcovaru, Cristina Bică, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1322-1322
Open Access | Times Cited: 2
Teodor Salmen, Claudia-Gabriela Potcovaru, Cristina Bică, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1322-1322
Open Access | Times Cited: 2
RETRACTED: A feasibility study of the combination of intranasal insulin with dulaglutide for cognition in older adults with metabolic syndrome at high dementia risk – Study rationale and design
Tal Davidy, Iscka Yore, Tali Cukierman‐Yaffe, et al.
Mechanisms of Ageing and Development (2023) Vol. 213, pp. 111825-111825
Closed Access | Times Cited: 4
Tal Davidy, Iscka Yore, Tali Cukierman‐Yaffe, et al.
Mechanisms of Ageing and Development (2023) Vol. 213, pp. 111825-111825
Closed Access | Times Cited: 4
Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trial
Matthew P. Gilbert, Joan M. Skelly, Adrian F. Hernandez, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 5, pp. 1714-1722
Open Access | Times Cited: 1
Matthew P. Gilbert, Joan M. Skelly, Adrian F. Hernandez, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 5, pp. 1714-1722
Open Access | Times Cited: 1
Comment on Kutz et al. Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes. Diabetes Care 2023;46:2004–2014
Giuseppe Maltese, Alan J. Sinclair
Diabetes Care (2024) Vol. 47, Iss. 4, pp. e32-e33
Open Access | Times Cited: 1
Giuseppe Maltese, Alan J. Sinclair
Diabetes Care (2024) Vol. 47, Iss. 4, pp. e32-e33
Open Access | Times Cited: 1
Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD ‐11 trial
Juan P. Frías, Enzo Bonora, Luis Nevárez Ruiz, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 10, pp. 2279-2288
Open Access | Times Cited: 9
Juan P. Frías, Enzo Bonora, Luis Nevárez Ruiz, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 10, pp. 2279-2288
Open Access | Times Cited: 9
Newer Glucose-Lowering Therapies in Older Adults with Type 2 Diabetes
Anika Bilal, Richard E. Pratley
Endocrinology and Metabolism Clinics of North America (2023) Vol. 52, Iss. 2, pp. 355-375
Closed Access | Times Cited: 3
Anika Bilal, Richard E. Pratley
Endocrinology and Metabolism Clinics of North America (2023) Vol. 52, Iss. 2, pp. 355-375
Closed Access | Times Cited: 3
Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors
Katherine Young, Eram Haider McInnes, Robert Massey, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Katherine Young, Eram Haider McInnes, Robert Massey, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Algoritmo de tratamiento de la diabetes mellitus tipo 2. RedGDPS 2023
Francisco Javier García Soidán
Diabetes práctica (2023) Vol. 14, Iss. 2, pp. 43-52
Open Access | Times Cited: 3
Francisco Javier García Soidán
Diabetes práctica (2023) Vol. 14, Iss. 2, pp. 43-52
Open Access | Times Cited: 3
Efficacy and safety outcomes of dulaglutide by baseline HbA1c : A post hoc analysis of the REWIND trial
Edward Franek, Hertzel C. Gerstein, Matthew C. Riddle, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 9, pp. 1753-1761
Open Access | Times Cited: 4
Edward Franek, Hertzel C. Gerstein, Matthew C. Riddle, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 9, pp. 1753-1761
Open Access | Times Cited: 4
The use of SGLT2 inhibitors and GLP-1 receptor agonists in older patients: a debate on approaches in CKD and non-CKD populations
Sophie Liabeuf, Roberto Minutolo, Jürgen Floege, et al.
Clinical Kidney Journal (2024) Vol. 18, Iss. 2
Open Access
Sophie Liabeuf, Roberto Minutolo, Jürgen Floege, et al.
Clinical Kidney Journal (2024) Vol. 18, Iss. 2
Open Access
Management of Type 2 Diabetes Mellitus in the Very Elderly: One Practice’s Experience
Martin M. Grajower, Derek LeRoith
Endocrine Practice (2023) Vol. 29, Iss. 7, pp. 560-565
Closed Access | Times Cited: 1
Martin M. Grajower, Derek LeRoith
Endocrine Practice (2023) Vol. 29, Iss. 7, pp. 560-565
Closed Access | Times Cited: 1
The use of the GLP-1 analog - dulaglutide in the treatment of morbid obesity - case report
Agata JUDA, Kornelia Rojek, Magdalena Kamińska, et al.
Journal of Education Health and Sport (2022) Vol. 13, Iss. 1, pp. 146-152
Open Access | Times Cited: 1
Agata JUDA, Kornelia Rojek, Magdalena Kamińska, et al.
Journal of Education Health and Sport (2022) Vol. 13, Iss. 1, pp. 146-152
Open Access | Times Cited: 1
Alul- és túlkezelés az idős cukorbeteg gondozása során
Zsolt Domboróczki, G Molnár
Diabetologia Hungarica (2022) Vol. 30, Iss. 5, pp. 373-378
Open Access | Times Cited: 1
Zsolt Domboróczki, G Molnár
Diabetologia Hungarica (2022) Vol. 30, Iss. 5, pp. 373-378
Open Access | Times Cited: 1
Neuroprotective potential of incretinomimetics
A. S. Kokin, Л. А. Суплотова, T. S. Dushina, et al.
Meditsinskiy sovet = Medical Council (2023) Vol. 17, Iss. 9, pp. 40-46
Open Access
A. S. Kokin, Л. А. Суплотова, T. S. Dushina, et al.
Meditsinskiy sovet = Medical Council (2023) Vol. 17, Iss. 9, pp. 40-46
Open Access
REWIND Diabetes for Octogenarians
Tarekegn Geberhiwot
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 7, pp. e2811-e2812
Open Access
Tarekegn Geberhiwot
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 7, pp. e2811-e2812
Open Access
